ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
TD Income Builder ETF

TD Income Builder ETF (TPAY)

21.21
0.00
(0.00%)
Cerrado 01 Enero 3:12PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
21.21
Postura de Compra
21.20
Postura de Venta
21.24
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
0.00 Rango de 52 semanas 0.00
Precio Anterior
21.21
Precio de Apertura
-
Hora
Última hora de negociación
Volumen promedio (3 m)
-
Volumen financiero
-
Precio Promedio Ponderado
-

TPAY Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
BDMDBaird Medical Investment Holdings Ltd
US$ 7.6699
(630.47%)
89.74M
APMAptorum Group Ltd
US$ 2.799
(106.57%)
116.74M
COEPCoeptis Therapeutics Holdings Inc
US$ 5.44
(75.48%)
5.08M
VRMEVerifyMe Inc
US$ 1.332
(68.63%)
94.04M
VEEETwin Vee PowerCats Company
US$ 0.55
(53.59%)
5.62M
WATTEnergous Corporation
US$ 1.00
(-62.26%)
29.33M
SGMOSangamo Therapeutics Inc
US$ 1.02
(-56.41%)
44.56M
INTZIntrusion Inc
US$ 3.07
(-45.95%)
15.07M
KZIAKazia Therapeutics Ltd
US$ 1.78
(-42.58%)
708.99k
TOIIWOncology Institute Inc
US$ 0.0052
(-42.22%)
366.02k
SVMHSRIVARU Holding Ltd
US$ 0.0423
(26.65%)
794.74M
XTIAXTI Aerospace Inc
US$ 0.0422
(6.84%)
446.31M
EYENEyenovia Inc
US$ 0.1474
(30.10%)
412.83M
CRKNCrown Electrokinetics Corporation
US$ 0.146899
(5.91%)
402.05M
ONCOOnconetix Inc
US$ 0.6479
(48.26%)
270.47M
NITE/$TOCKER NITE/$TOCKER 5 minutos hace
https://images.app.goo.gl/YPZwTngGA4JgxyD7A
XRPUSD
Dragonman1 Dragonman1 5 minutos hace
NO the biggest scam of 2025 is you MF, get a life, stop trying to sway newbies away from a fantastic beer co, how much do they pay you for posting this garbage talk!
KEGS
haha11 haha11 5 minutos hace
HAPPY NEW YEAR 2025 TO ALL...
Jetmek_03052 Jetmek_03052 5 minutos hace
Not only that - 1/3 of DBMM’s 2025 fiscal year has already slipped by. And no new clients have been signed on. No new clients equates to no new revenue.

They’d better get going, eh?
DBMM
Bubae Bubae 6 minutos hace
Seriously? RDAR? 🤣 They are currently delinquent in their filings and listed as a shell risk. With those circumstances I have to question how much longer before their listing is dropped. They had a regulation "A" offering qualified by the SEC in March 2024 and just filed for another on Novem
RDAR
familyof5 familyof5 6 minutos hace
The notorious ihub PSYOP crew lol. Why throw a rock then hide your hand. You struggle to understand the unknown yet you claim to have an answer for everything lol.




EmpressMonk25 Re: TenKay post# 128769
Saturday, 12/28/2024 6:31:36 PM

Ca
HMBL
Lakota-45 Lakota-45 6 minutos hace
~ "Happy New Year" - To all the Longs, and . . .
Good Luck in the - New Year !!!

~ $INQD ~
INQD
janice shell janice shell 7 minutos hace
Wow. Once in college I mixed those two and literally couldn't sleep for 24 hours. And for the first six, I couldn't sit still.
janice shell janice shell 8 minutos hace
LOL!!
catdaddy catdaddy 9 minutos hace
Good stuff!
“To our knowledge this is the first report of a therapeutic agent for AD that has demonstrated an attenuation in global brain volume loss measured by MRI and reduction of the expansion of the lateral ventricular volume compared to placebo. Volumetric MRI improvements associated wi
AVXL
jimr1717 jimr1717 9 minutos hace
Latest ATMH DD>> 🏆️


Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobil
ATMH
StonkMaster StonkMaster 10 minutos hace
So it took nearly a year from the first CHM meeting to approve a drug that is already approved elsewhere worldwide? That's not super encouraging.
NWBO
RobotDroid RobotDroid 11 minutos hace
Inept mute nonmanagement is silent because they only have bad news to report. This clown show continues into 2025 and will only get worse as long as Linda the Grifter Worthless is in charge.
NWBO
baltimorebullet baltimorebullet 11 minutos hace
Do we have insider information?
AVXL
LTListener LTListener 12 minutos hace
You would think listing correct management and BOD would be important!

And all 3 platforms have way outdated information!

It is illogical to cry about lack of funding and otc liquidity when you present the company like a 6th grade science project..

Yet ex
RSPI
dbergh dbergh 12 minutos hace
The Trump Sequel: What to Expect on PBMs, 340B, Drug Pricing, and RFK Jr November 12, 2024

AJMC: The Federal Trade Commission has been very active in looking into practices of PBMs, even pursuing litigation. As you noted, litigation between administrations does not always continue.
PBM
Guido2 Guido2 12 minutos hace
I side with Patswil.
FNMA
weedtrader420 weedtrader420 13 minutos hace
🖕🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🤑🖕
XRPUSD
weedtrader420 weedtrader420 13 minutos hace
😵😵😵
XRPUSD
northam43 northam43 14 minutos hace
Report 9.1 SPX Cycles 12 Month Low/High Projection Range

https://investorshub.advfn.com/uimage/uploads/2025/1/1/qugqx9.1_12_Month_Range.PNG
dedugan dedugan 15 minutos hace
I would like everything you said to be true.
But you said "We have had a number of sources close to Moez Kassam write to inform us that Moez/Anson have recently received a sealed indictment.
According to these sources they have been found guilty."
An indictment is not a guilty
NWBO
capgain capgain 15 minutos hace
Fingerprint File (Live / Remastered 2009)

https://www.youtube.com/watch?v=Hcr-wMyFY2s
Lykiri Lykiri 16 minutos hace
It wasn’t an easy task, but I concluded that there were probably 3 or 4.

Here is medicine number 4, approved by MHRA on 31 December 2024.

Tarlatamab approved to treat adult patients with small cell lung cancer.

The Medicines and Healthcare products Regula
NWBO
northam43 northam43 16 minutos hace
Report 9.1 SPX Cycles 12 Month Low/High Projection Range

https://investorshub.advfn.com/uimage/uploads/2025/1/1/qugqx9.1_12_Month_Range.PNG
NoMoDo NoMoDo 16 minutos hace
Don't tell me scores, because I am delayed a bit. But yes, dominating.
HMBL

Su Consulta Reciente

Delayed Upgrade Clock